US authorities weigh whether to resume J&J vaccine use

New guidance is expected after a government advisory panel deliberates on a link between the shot and rare blood clots.

This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.

Accept Learn more…